Clinical Trial Record

Return to Clinical Trials

Endoscopic Ultrasound-guided Drainage of Pancreatic Pseudocysts


2017-02


2017-10


2017-12


106

Study Overview

Endoscopic Ultrasound-guided Drainage of Pancreatic Pseudocysts

The purpose of this study is to compare the effect of lumen-apposing metal stent (LAMS) and traditional plastic stent on the drainage of pancreatic pseudocyst, mainly to observe the cyst recurrence rate of 12 months after treatment.

Inclusion criteria 1. Subject with ages from 18-80 years old 2. Subject with pancreatic pseudocysts confirmed by CT 3. Subject with a history of MSAP or SAP, the pseudocysts were formed more than 3 months 4. The size of pseudocyst is more than 6 cm, and the cyst adjacent to the gastric wall 5. Subject has the symptoms related with the pseudocyst 6. The consent form has been signed Exclusion criteria 1. Subject is younger than 18 years or older than 80 years 2. Pancreatic pseudocyst communicate with the main pancreatic duct 3. Subject can't accept the endoscopic procedure 4. Pancreatic pseudocyst with infection or subject diagnosed with pancreatic abscess 5. The distance between gastric and the wall of the pseudocyst is more than 1 cm 6. Subject with 2 or more than 2 cysts 7. Subject has blood coagulation dysfunction 8. Pregnant or subject has mental disorders

  • Pancreatic Pseudocyst
  • DEVICE: Endoscopic Ultrasound-guided Drainage
  • 2017010301

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2017-01-11  

N/A  

2017-01-12  

2017-01-12  

N/A  

2017-01-16  

2017-01-16  

N/A  

2017-01  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Treatment


Allocation:
Randomized


Interventional Model:
Parallel


Masking:
None


Arms and Interventions

Participant Group/ArmIntervention/Treatment
ACTIVE_COMPARATOR: plastic stent

Endoscopic Ultrasound-guided Drainage with plastic stent

DEVICE: Endoscopic Ultrasound-guided Drainage

  • Pancratic pseudocyst drainaged under the guide of Endoscopic Ultrasound
EXPERIMENTAL: lumen-apposing metal stent (LAMS)

Endoscopic Ultrasound-guided Drainage with lumen-apposing metal stent

DEVICE: Endoscopic Ultrasound-guided Drainage

  • Pancratic pseudocyst drainaged under the guide of Endoscopic Ultrasound
Primary Outcome MeasuresMeasure DescriptionTime Frame
Cyst recurrence rateup to 12 months
Secondary Outcome MeasuresMeasure DescriptionTime Frame
Technical success rateup to 48 hours
Clinical success rateup to 12 months
Complication rateup to 12 months

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:
    1. Subject with ages from 18-80 years old 2. Subject with pancreatic pseudocysts confirmed by CT 3. Subject with a history of MSAP or SAP, the pseudocysts were formed more than 3 months 4. The size of pseudocyst is more than 6 cm, and the cyst adjacent to the gastric wall 5. Subject has the symptoms related with the pseudocyst 6. The consent form has been signed
    Exclusion Criteria:
    1. Subject is younger than 18 years or older than 80 years 2. Pancreatic pseudocyst communicate with the main pancreatic duct 3. Subject can't accept the endoscopic procedure 4. Pancreatic pseudocyst with infection or subject diagnosed with pancreatic abscess 5. The distance between gastric and the wall of the pseudocyst is more than 1 cm 6. Subject with 2 or more than 2 cysts 7. Subject has blood coagulation dysfunction 8. Pregnant or subject has mental disorders

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available